Portland, OR -- (SBWire) -- 09/22/2017 --The global smart insulin pens market was valued at $57 million in 2016, and is projected to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023. The first generation pens segment held more than three-fifths share of the total market in 2016.
The smart insulin pen is used to deliver insulin to diabetic patients. Increase in demand for self-injection devices, a rise in prevalence of diabetes, and accuracy in dosage delivery of insulin are expected to drive the market growth. However, limited usage of smart insulin pens for patients requiring a mixture of two types of insulin restrict the market growth.
First generation pens are expected to dominate the market throughout the analysis period. However, the second generation pens segment is expected to register the highest CAGR of 12.3%.
Get TOC and Sample Copy: https://www.alliedmarketresearch.com/request-sample/3485
Key Findings of the Smart Insulin Pens Market :
-The first generation pen is projected to grow at the CAGR of 9.7% during the forecast period.
-USB connected pen is projected to register the highest growth rate of 12.7% during the forecast period.
-Bluetooth-enabled pens segment accounted the nearly two-thirds share of the global second-generation smart insulin pens market in 2016.
-Home care setting is expected to grow at the highest CAGR of 10.9% during the forecast period.
-France and Germany collectively contributed more than one-third share of the European smart insulin pens market in 2016.
-Japan was the major shareholder in 2016, accounting for more than one-third share of the Asia-Pacific smart insulin pens market.
Get Customized Report: https://www.alliedmarketresearch.com/request-for-customization/3485
Asia-Pacific is projected to register the highest CAGR of 12.0%, owing to rise in the incidence of diabetes coupled with rising geriatric population. In addition, a surge in awareness of benefits of smart insulin pens, such as it is beneficial for people with vision problems, offers a lucrative opportunity for the market growth.
The major companies profiled in the report are Eli Lilly and Company, Novo Nordisk, Companion Medical, DIAMESCO, and Emperra GmbH.
Smart Insulin Pens Market by Type, Usability and End User, 2023